Daclatasvir plus Sofosbuvir with or without Ribavirin in Patients with HCV Infection and Decompensated Cirrhosis: Interim Analysis of a French Multicentre Compassionate use Programme
V. Leroy
,
C. Hezode
,
S. Metivier
,
M. Tateo
,
F. Conti
et al.
Journal articles
hal-03590935v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
P1266 : Human albumin use in cirrhotic patients in France: Results of the national “Albu-live” survey
A. Garioud
,
J. -F. Cadranel
,
A. Pauwels
,
T. Thevenot
,
A. Louvet
et al.
The International Liver Congress™ 2015 – 50th Annual meeting of the European Association for the Study of the Liver , Apr 2015, Vienne, Austria. 62, Supplement 2, pp.S833, 2015,
⟨10.1016/S0168-8278(15)31461-6⟩
Conference poster
hal-01162774v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
LEDIPASVIR/SOFOSBUVIR IN NS3/4A PROTEASE INHIBITOR-EXPERIENCED SUBJECTS WITH HCV GENOTYPE 1 AND HIV-COINFECTION FINAL RESULTS OF THE ANRS HC31 SOFTRIH STUDY
E. Rosenthal
,
C. Fougerou-Leurent
,
A. Renault
,
E. Teicher
,
S. Dominguez
et al.
Journal of Hepatology , 2016, 64, pp.S764--S764
Journal articles
hal-01533344v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Should we keep using Ribavirin to Treat Hepatitis C Recurrence after Liver Transplantation? Results from the CO23 ANRS Cupilt Study
P. Houssel-Debry
,
C. Duvoux
,
A. Coilly
,
C. Fougerou-Leurent
,
C. Jezequel
et al.
Journal articles
hal-01533345v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
P0804 : Efficacy of sofosbuvir-based treatment regimens in HIV/HCV co-infected patients after liver transplantation: The ANRS CO23 CUPILT study
T. M. Antonini
,
A. Coilly
,
S. Radenne
,
A. Veislinger
,
D. Botta-Fridlund
et al.
The International Liver Congress™ 2015 – 50th Annual meeting of the European Association for the Study of the Liver , Apr 2015, Vienne, Austria. 62, Supplement 2, pp.S635--S636, 2015,
⟨10.1016/S0168-8278(15)31007-2⟩
Conference poster
hal-01162778v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More